NYSE:DOC - Physicians Realty Trust Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $18.58 +0.27 (+1.47 %) (As of 05/21/2019 04:00 PM ET)Previous Close$18.31Today's Range$18.33 - $18.6952-Week Range$14.62 - $19.16Volume1.08 million shsAverage Volume1.25 million shsMarket Capitalization$3.44 billionP/E Ratio17.20Dividend Yield5.02%Beta0.59 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Physicians Realty Trust (NYSE:DOC) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.9 Wall Street analysts have issued ratings and price targets for Physicians Realty Trust in the last 12 months. Their average twelve-month price target is $18.1333, suggesting that the stock has a possible downside of 2.40%. The high price target for DOC is $19.00 and the low price target for DOC is $17.45. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.562.672.672.69Ratings Breakdown: 0 Sell Rating(s)4 Hold Rating(s)5 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $18.1333$18.00$17.5455$17.75Price Target Upside: 2.40% downside5.66% downside6.53% upside7.77% upsidePhysicians Realty Trust (NYSE:DOC) Consensus Price Target History Physicians Realty Trust (NYSE:DOC) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails5/7/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$17.45High5/2/2019Capital One FinancialDowngradeOverweight ➝ Equal Weight$18.75Low3/28/2019Morgan StanleySet Price TargetHold$19.00Medium11/5/2018B. RileyReiterated RatingBuyLow9/10/2018KeyCorpBoost Price TargetOverweight ➝ Buy$17.00 ➝ $18.00Medium8/13/2018Jefferies Financial GroupReiterated RatingHold$18.00Low8/7/2018Royal Bank of CanadaReiterated RatingBuy$18.00Low8/7/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$17.00 ➝ $18.00Low8/2/2018Cantor FitzgeraldReiterated RatingBuy$18.00High4/24/2018Stifel NicolausDowngradeBuy ➝ Hold$18.00 ➝ $17.00Medium3/8/2018Bank of AmericaLower Price TargetBuy ➝ Buy$19.50 ➝ $18.00Low2/28/2018SunTrust BanksSet Price TargetHold$16.00Low12/7/2017Raymond JamesSet Price TargetBuy$20.00Low7/17/2017UBS GroupDowngradeStrong-Buy ➝ OutperformLow7/11/2017FBR & CoReiterated RatingOutperform$21.00Low(Data available from 5/21/2017 forward) This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: What are the qualifications of a portfolio manager? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.